Home HOME Neoplasma 2019 Neoplasma Vol.66, No.4, p.516-523, 2019

Journal info

6 times a year.
Founded: 1954
ISSN 0028-2685
ISSN 1338-4317 (online)

Published in English

Editorial Info
Abstracted and Indexed
Submission Guidelines

Select Journal

Webshop Cart

Your Cart is currently empty.

Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.

Neoplasma Vol.66, No.4, p.516-523, 2019

Title: Exosomal miRNA423-5p mediated oncogene activity in papillary thyroid carcinoma: a potential diagnostic and biological target for cancer therapy
Author: W. Ye, X. Deng, Y. Fan

Abstract: Exosomes are considered important “messengers” between cells and their cargo, and some of the miRNAs composing their cargo may be involved in oncogenic activity. Exosomal miRNA423-5p (Ex-miRNA423-5p) is upregulated in gastric cancer and associated with its poor prognosis. However, the role of exosome-derived miRNAs in papillary thyroid cancer (PTC) is still unclear and needs further study. In our work, we found that the level of Ex-miRNA423-5p was significantly increased in the serum of PTC patients compared with the serum of normal healthy people, and in vitro, we demonstrated that miRNA423-5p entered thyroid cancer cells through exosomes from thyroid cancer cell supernatant. Functional experiments demonstrated that overexpression of miRNA423-5p mimics in exosomes increased PTC cell migration and invasion, while the silencing of miRNA423-5p in TPC-1 cell exosomes inhibited PTC cell migration and invasion in vitro. These findings indicate that Ex-miRNA423-5p might serve as a potential tumor marker; thus, silencing miRNA423-5p in exosomes might represent a potential approach against PTC.

Keywords: exosome, miRNA423-5p, papillary thyroid carcinoma, migration, invasion
Published online: 29-Jul-2019
Year: 2019, Volume: 66, Issue: 4 Page From: 516, Page To: 523

download file

© AEPress s.r.o
Copyright notice: For any permission to reproduce, archive or otherwise use the documents in the ELiS, please contact AEP.